These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24083172)

  • 1. Association of metabolic syndrome with schizophrenia.
    Bajaj S; Varma A; Srivastava A; Verma AK
    Indian J Endocrinol Metab; 2013 Sep; 17(5):890-5. PubMed ID: 24083172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is abnormal non-high-density lipoprotein cholesterol a gender-specific predictor for metabolic syndrome in patients with schizophrenia taking second-generation antipsychotics?
    Lin EC; Shao WC; Yang HJ; Yen M; Lee SY; Wu PC; Lu RB
    Metab Brain Dis; 2015 Feb; 30(1):107-13. PubMed ID: 25034455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome in schizophrenia: Differences between antipsychotic-naïve and treated patients.
    Chadda RK; Ramshankar P; Deb KS; Sood M
    J Pharmacol Pharmacother; 2013 Jul; 4(3):176-86. PubMed ID: 23960422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review.
    Sneller MH; de Boer N; Everaars S; Schuurmans M; Guloksuz S; Cahn W; Luykx JJ
    Front Psychiatry; 2021; 12():625935. PubMed ID: 33868046
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics.
    Fang X; Wang Y; Chen Y; Ren J; Zhang C
    Neuropsychiatr Dis Treat; 2019; 15():2161-2170. PubMed ID: 31534339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics.
    Correll CU; Frederickson AM; Kane JM; Manu P
    Bipolar Disord; 2008 Nov; 10(7):788-97. PubMed ID: 19032710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review.
    De Hert M; Schreurs V; Sweers K; Van Eyck D; Hanssens L; Sinko S; Wampers M; Scheen A; Peuskens J; van Winkel R
    Schizophr Res; 2008 Apr; 101(1-3):295-303. PubMed ID: 18299188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population.
    Rawat VS; Ganesh S; Bijjal S; Shanivaram Reddy K; Agarwal V; Devi R; Kumar CN; Christopher R; Thirthalli J
    Schizophr Res; 2018 Feb; 192():102-107. PubMed ID: 28454923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome.
    Kornetova EG; Kornetov AN; Mednova IA; Dubrovskaya VV; Boiko AS; Bokhan NA; Loonen AJM; Ivanova SA
    Front Psychiatry; 2019; 10():803. PubMed ID: 31736812
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative Characteristics of the Metabolic Syndrome Prevalence in Patients With Schizophrenia in Three Western Siberia Psychiatric Hospitals.
    Kornetova EG; Kornetov AN; Mednova IA; Goncharova AA; Gerasimova VI; Pozhidaev IV; Boiko AS; Semke AV; Loonen AJM; Bokhan NA; Ivanova SA
    Front Psychiatry; 2021; 12():661174. PubMed ID: 34276438
    [No Abstract]   [Full Text] [Related]  

  • 11. A two fold risk of metabolic syndrome in a sample of patients with schizophrenia: do consanguinity and family history increase risk?
    Bener A; Al-Hamaq AO; Dafeeah EE
    Diabetes Metab Syndr; 2014; 8(1):24-9. PubMed ID: 24661754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Easy and low-cost identification of metabolic syndrome in patients treated with second-generation antipsychotics: artificial neural network and logistic regression models.
    Lin CC; Bai YM; Chen JY; Hwang TJ; Chen TT; Chiu HW; Li YC
    J Clin Psychiatry; 2010 Mar; 71(3):225-34. PubMed ID: 19814949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome among inpatients with schizophrenia.
    Boke O; Aker S; Sarisoy G; Saricicek EB; Sahin AR
    Int J Psychiatry Med; 2008; 38(1):103-12. PubMed ID: 18624022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome among psychiatric inpatients with schizophrenia in Indonesia.
    Marthoenis M; Aichberger MC; Puteh I; Syahrial S; Schouler-Ocak M
    Asian J Psychiatr; 2015 Jun; 15():10-4. PubMed ID: 25910596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Evolution of Metabolic Status in Patients with Schizophrenia Stably Maintained on Second-Generation Antipsychotics.
    Jeong SH; Lee NY; Kim SH; Chung IW; Youn T; Kang UG; Ahn YM; You HY; Kim YS
    Psychiatry Investig; 2018 Jun; 15(6):628-637. PubMed ID: 29940717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome among patients with schizophrenia in Japan.
    Sugawara N; Yasui-Furukori N; Sato Y; Umeda T; Kishida I; Yamashita H; Saito M; Furukori H; Nakagami T; Hatakeyama M; Nakaji S; Kaneko S
    Schizophr Res; 2010 Nov; 123(2-3):244-50. PubMed ID: 20850274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
    Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
    Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher prevalence of metabolic syndrome and related factors in patients with first-episode psychosis and schizophrenia: a cross-sectional study in Turkey.
    Sahpolat M; Ari M
    Nord J Psychiatry; 2021 Jan; 75(1):73-78. PubMed ID: 32886012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome in first episode schizophrenia - a randomized double-blind controlled, short-term prospective study.
    Saddichha S; Manjunatha N; Ameen S; Akhtar S
    Schizophr Res; 2008 Apr; 101(1-3):266-72. PubMed ID: 18262771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis.
    Vancampfort D; Stubbs B; Mitchell AJ; De Hert M; Wampers M; Ward PB; Rosenbaum S; Correll CU
    World Psychiatry; 2015 Oct; 14(3):339-47. PubMed ID: 26407790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.